Literature DB >> 21858418

Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane.

Ulana Kotowski1, Gregor Heiduschka, Markus Brunner, Cornelia Czembirek, Christina Eder-Czembirek, Rainer Schmidt, Tammer Fahim, Dietmar Thurnher.   

Abstract

BACKGROUND AND
PURPOSE: Sulforaphane is a naturally occurring compound found in broccoli and other cruciferous vegetables. Recently it gained attention because of its antiproliferative properties in many cancer cell lines. The aim of this study was to investigate whether sulforaphane could act as a radiosensitizer in head and neck squamous cell carcinoma cell lines.
MATERIALS AND METHODS: Four head and neck squamous cell carcinoma cell lines (i.e., (HNSCC) SCC9, SCC25, CAL27, and FADU) were treated with sulforaphane and subsequently irradiated. Then proliferation and clonogenic assays were performed. Apoptosis was detected by flow cytometry. Possible regulation of Akt and Mcl-1 was investigated by western blotting.
RESULTS: Sulforaphane and radiation in combination leads to stronger inhibition of cell proliferation and of clonogenic survival than each treatment method alone. Western blot analysis of Akt and Mcl-1 showed no changed expression.
CONCLUSION: Sulforaphane is a promising agent in the treatment of head and neck cancer due to its antiproliferative and radio-sensitizing properties. A combination of sulforaphane and radiation decreases clonogenic survival. Apoptosis is not regulated through Akt or the Mcl-1 protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858418     DOI: 10.1007/s00066-011-2218-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  28 in total

Review 1.  Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.

Authors:  Ting-Chao Chou
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

2.  High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer.

Authors:  Hendrik Andreas Wolff; Jan Bosch; Klaus Jung; Tobias Overbeck; Steffen Hennies; Christoph Matthias; Clemens F Hess; Ralph M Roedel; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

3.  Regulators of proliferation and apoptosis in carcinoma of the larynx.

Authors:  L C Whisler; N B Wood; D D Caldarelli; J C Hutchinson; W R Panje; M Friedman; H D Preisler; S Leurgans; J Nowak; J S Coon
Journal:  Laryngoscope       Date:  1998-05       Impact factor: 3.325

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes.

Authors:  K Mahéo; F Morel; S Langouët; H Kramer; E Le Ferrec; B Ketterer; A Guillouzo
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

Review 6.  Sulforaphane as a promising molecule for fighting cancer.

Authors:  Carmela Fimognari; Patrizia Hrelia
Journal:  Mutat Res       Date:  2006-11-28       Impact factor: 2.433

7.  7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma.

Authors:  Gregor Heiduschka; Boban M Erovic; Laurenz Vormittag; Christiane Skoda; Helga Martinek; Markus Brunner; Klaus Ehrenberger; Dietmar Thurnher
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-03

8.  Chemopreventive agent sulforaphane enhances radiosensitivity in human tumor cells.

Authors:  Dong Yu; Emiko Sekine-Suzuki; Lian Xue; Akira Fujimori; Nobuo Kubota; Ryuichi Okayasu
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

9.  Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis.

Authors:  Diana Steinmann; Bettina Cerny; Johann Hinrich Karstens; Michael Bremer
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

10.  Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway.

Authors:  Marc A Riedl; Andrew Saxon; David Diaz-Sanchez
Journal:  Clin Immunol       Date:  2008-11-22       Impact factor: 3.969

View more
  11 in total

1.  The effect of cilengitide in combination with irradiation and chemotherapy in head and neck squamous cell carcinoma cell lines.

Authors:  G Heiduschka; C Lill; S Schneider; R Seemann; G Kornek; R Schmid; U Kotowski; D Thurnher
Journal:  Strahlenther Onkol       Date:  2014-02-21       Impact factor: 3.621

2.  The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and Tumors.

Authors:  Vanessa Vanderdys; Amir Allak; Fadila Guessous; Mouadh Benamar; Paul W Read; Mark J Jameson; Tarek Abbas
Journal:  Mol Cancer Ther       Date:  2017-08-24       Impact factor: 6.261

3.  Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures.

Authors:  Lorenz Kadletz; Gregor Heiduschka; Julian Domayer; Rainer Schmid; Elisabeth Enzenhofer; Dietmar Thurnher
Journal:  Oncol Lett       Date:  2015-07-14       Impact factor: 2.967

4.  Radiation induced a supra-additive cytotoxic effect in head and neck carcinoma cell lines when combined with plant extracts from Brazilian Cerrado biome.

Authors:  Silvia T Elias; Gabriel A Borges; Danilo A Amorim; Daniela F Rêgo; Luiz A Simeoni; Dâmaris Silveira; Yris Maria Fonseca-Bazzo; José E Paula; Christopher William Fagg; Ivelone M C Barros; Wenzel C Abreu; Décio S Pinto-Júnior; Pérola O Magalhães; Francisco A R Neves; Adriana Lofrano-Porto; Eliete N S Guerra
Journal:  Clin Oral Investig       Date:  2014-08-07       Impact factor: 3.573

5.  The effect of resveratrol in combination with irradiation and chemotherapy: study using Merkel cell carcinoma cell lines.

Authors:  G Heiduschka; C Lill; R Seemann; M Brunner; R Schmid; R Houben; J Bigenzahn; D Thurnher
Journal:  Strahlenther Onkol       Date:  2013-11-08       Impact factor: 3.621

Review 6.  Molecular targets of isothiocyanates in cancer: recent advances.

Authors:  Parul Gupta; Bonglee Kim; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Mol Nutr Food Res       Date:  2014-02-10       Impact factor: 5.914

7.  Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines.

Authors:  Ulana Kotowski; Gregor Heiduschka; Rudolf Seemann; Julia Eckl-Dorna; Rainer Schmid; Veronika Kranebitter; Isabella Stanisz; Markus Brunner; Claudia Lill; Dietmar Thurnher
Journal:  Strahlenther Onkol       Date:  2015-01-10       Impact factor: 3.621

8.  Isoalantolactone Enhances the Radiosensitivity of UMSCC-10A Cells via Specific Inhibition of Erk1/2 Phosphorylation.

Authors:  Yonggang Fan; Zhiyong Weng; Hongguo Gao; Jiehua Hu; Hongyan Wang; Lihua Li; Hua Liu
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

9.  Sulforaphane enhances irradiation effects in terms of perturbed cell cycle progression and increased DNA damage in pancreatic cancer cells.

Authors:  Patrick Naumann; Jakob Liermann; Franco Fortunato; Thomas E Schmid; Klaus-Josef Weber; Jürgen Debus; Stephanie E Combs
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

10.  Combined Treatment with Low Cytotoxic Ethyl Acetate Nepenthes Extract and Ultraviolet-C Improves Antiproliferation to Oral Cancer Cells via Oxidative Stress.

Authors:  Sheng-Yao Peng; Li-Ching Lin; Zhe-Wei Yang; Fang-Rong Chang; Yuan-Bin Cheng; Jen-Yang Tang; Hsueh-Wei Chang
Journal:  Antioxidants (Basel)       Date:  2020-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.